Dr. Andrew H. Zwick, MD

Dr. Zwick practices at Gastro Health in Boca Raton, Florida.

Dr. Zwick's NPI, 1003814922, was assigned on July 13, 2005. Dr. Zwick graduated from University of Miami, Miller School of Medicine in 1990. Dr. Zwick holds Florida license ME65365.

Dr. Zwick's primary practice is Gastro Health, at 9970 Central Park N Blvd, Boca Raton, FL 33428 in Palm Beach County. The practice phone is (305) 913-0666.

Dr. Zwick's primary practice is Gastro Health in Boca Raton, Florida. Dr. Zwick is also affiliated with West Boca Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Zwick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zwick practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Zwick's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Zwick's licenses on file in 3 states: Florida, New York and Maryland.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Zwick treats.

CMS data shows 753 Medicare services from Dr. Zwick across 14 procedure codes in 2024, for 429 Medicare patients. Medicare paid $73,224 for them.

CMS counts 429 Medicare patients who saw Dr. Zwick in 2024. The largest group is 75 to 84, with 174 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zwick's median patient age at 59, with 55% women.

In 2024, Dr. Zwick wrote 1,164 Medicare Part D claims for 328 patients. 78% of them were for generic drugs. CMS names the drug for 973 of them, across 20 drugs with 11 or more claims each, at $213,386 in total drug cost. In 2023, CMS named 773 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Zwick for performance year 2024, reported as part of a group. Dr. Zwick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Zwick, more than 69% of the clinicians it reports for that procedure.

Dmand AI links Dr. Zwick to 2 clinical trials. Conditions studied include Crohn Disease, Non-alcoholic Fatty Liver Disease and Fatty Liver. Open Payments lists research payments to Dr. Zwick that name 1 trial.

CMS Open Payments shows 718 general payments to Dr. Zwick from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbvie Inc. paid the most, $4,403. It also lists 2 research payments totaling $2,800 from 2016 to 2021, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Zwick, most recently CMS Stage 1 EHR in 2013.

Dr. Zwick graduated from University of Miami, Miller School of Medicine in 1990.

Dr. Zwick is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.